HopeStage
Back to all studies
TerminatedNCT02351869

Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolarity

Medication studyAges 20–60Canada
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 20 years to 60 years. Other eligibility criteria apply.

Listed locations
TorontoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateAugust 2015
Recruitment status
Terminated
Enrollment listed in the registry
25
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 20 Years to 60 Years
Official registry ID
NCT02351869
Official title
Show the full official title

Nitrous Oxide as a Putative Novel Dual-Mechanism Treatment for Bipolar Disorder

Recruitment & locations

Terminated

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Does this study involve medication?

Yes. The study involves medication, including Nitrous Oxide and Midazolam.

Who can participate?

This study is for people with bipolarity. Listed age limits: 20 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies